Look Beyond Bud Light ’s U.S. Boycott. The Rest of the World Is Buying AB InBev
Arguably the most famous New Yorker cover depicts the View of the World from ninth Avenue, in which Manhattan is at its center and makes up its bulk. It’s a self-admittedly myopic map, but one that demonstrates how easy it is to forget the rest of the globe, no matter one’s location.#newyorker #viewofworld #ninthavenue #manhattan
Source: Reuters: Health - August 12, 2023 Category: Consumer Health News Source Type: news

Target recalls 2.2 million candles that pose a safety threat
Target is recalling 2.2 million candles following reports that the glass jars containing them are “breaking or cracking during use,” resulting in one minor injury. In an alert issued Thursday, the Consumer Product Safety Commission said that the recalled Threshold candles are a 5.5-ounce, 1-wick…#cpsc #target
Source: Reuters: Health - August 12, 2023 Category: Consumer Health News Source Type: news

How Georgia ' s RICO laws could give Fani Willis a serious edge prosecuting Trump
Fulton County District Attorney Fani Willis, who has been investigating attempts to overturn the 2020 election in Georgia, is expected to present her case to a grand jury next week. The bulk of Willis’ investigation is likely to overlap with Jack Smith’s own federal investigation into attempts to…#fultoncounty #faniwillis #georgia #willis #jacksmith #jacksmiths #trump #rico #departmentofjustice #atlanta
Source: Reuters: Health - August 10, 2023 Category: Consumer Health News Source Type: news

Why XRP Is Falling Today: Here Are Major Reasons
XRP has continued to shed some of the gains picked up on July 13 due to several factors contributing to bearish sentiments and large-scale selling pressure. XRP has printed three consecutive losing candles over the past three days. A bearish start to the day has seen the asset drop by an…#xrp #ussec #johndeaton #ripplesclo #stuartalderoty #analisatorres #sdnydistrict #jedrakoff #terraformlabs #courtofappeals
Source: Reuters: Health - August 5, 2023 Category: Consumer Health News Source Type: news

India still heavily reliant on China for life saving drugs despite PLI booster: Report
India's pharma industry is heavily dependent on China for bulk drug imports, with 43% of total pharma imports originating from China, according to a report by CareEdge. Moreover, the use of bulk drugs from China has increased from 64% in fiscal year 2014 to 71% in FY23, the report added.
Source: The Economic Times Healthcare and Biotech News - August 4, 2023 Category: Pharmaceuticals Source Type: news

National champions now dominate in banking
Lenders outside US and Europe make up bulk of top 100 by market capitalisation
Source: Reuters: Health - August 3, 2023 Category: Consumer Health News Source Type: news

Top Dividend Stocks for August 2023
August's top dividend stocks include oil exploration firm Berry Corp. (BRY), marine shipping companies Genco Shipping & Trading Ltd. (GNK) and Eagle Bulk Shipping Inc. (EGLE), real estate investment trust (REIT) Apollo Commercial Real Estate Finance Inc. (ARI), and oil and gas company Pioneer…#berrycorp #bry #gnk #eaglebulkshippinginc #egle #ari #pxd #dividend #boardofdirectors #reit
Source: Reuters: Health - August 2, 2023 Category: Consumer Health News Source Type: news

Watch live
CHICAGO — At least 200 workers at Loretto Hospital on the city’s Southwest Side walked off the job Monday morning. Mental health workers, radiology technicians, and housekeepers make up the bulk of SEIU Healthcare. The workers claim they’re underpaid and understaffed, which is reflected by the…#lorettohospital #seiuhealthcare #wellingtonthomas #ericablanddurosinmi #blanddurosinmi #wgn #seiu #omaraquino
Source: Reuters: Health - August 1, 2023 Category: Consumer Health News Source Type: news

If the house caught fire, whom would you rescue: your partner, your dog or your identical twin?
Chloe Hamilton reflects on her intense relationship with Lydia, her twin sisterMy birthday in 2016 was a bit bleak. The paper I was working for had announced a tranche of redundancies and as a result I had to cancel a skiing holiday with my identical twin and our friends, so I could stay at home and fight for my job. At 8am, while Lydia was whizzing down pristine white slopes in Val d ’Isère, I was sitting in front of my editor, an expanse of pristine white desk between us, trying to convince him to keep me on. It was the first birthday my twin and I had spent apart. Through 25 years of twinhood – even when studying a...
Source: Guardian Unlimited Science - July 30, 2023 Category: Science Authors: Chloe Hamilton Tags: Family Life and style Psychology Science Health & wellbeing Source Type: news

If the house caught fire, who would you rescue, your partner, your dog or your identical twin?
Chloe Hamilton reflects on her intense relationship with Lydia, her twin sisterMy birthday in 2016 was a bit bleak. The paper I was working for had announced a tranche of redundancies and as a result I had to cancel a skiing holiday with my identical twin and our friends, so I could stay at home and fight for my job. At 8am, while Lydia was whizzing down pristine white slopes in Val d ’Isère, I was sitting in front of my editor, an expanse of pristine white desk between us, trying to convince him to keep me on. It was the first birthday my twin and I had spent apart. Through 25 years of twinhood – even when studying a...
Source: Guardian Unlimited Science - July 30, 2023 Category: Science Authors: Chloe Hamilton Tags: Family Life and style Psychology Science Health & wellbeing Source Type: news

Biogen Looks To Bulk Up Rare Disease Portfolio With $7.3 Billion Acquisition
Biogen will buy Reata Pharmaceuticals and its Friedreich's ataxia drug in a $7.3 billion deal.
Source: Forbes.com Healthcare News - July 28, 2023 Category: Pharmaceuticals Authors: Mary Whitfill Roeloffs, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news topline Source Type: news

Biogen to buy Reata for $6.5 billion to bulk up rare disease portfolio
Biogen said it would buy biotech firm Reata Pharmaceuticals for roughly $6.5 billion to expand its presence in the rare disease drugs market. Through the deal, Biogen will gain Plano, Texas-based Reata's recently approved drug Skyclarys to treat a rare genetic disorder that causes progressive…#biogen #reatapharmaceuticals #plano #reata #leqembi
Source: Reuters: Health - July 28, 2023 Category: Consumer Health News Source Type: news

Biogen to bulk up rare disease treatments with $7 billion Reata acquisition
Biogen is spending more than $7 billion to buy Reata Pharmaceuticals and bolster its rare disease treatments. The Alzheimer’s treatment developer said Friday it will pay $172.50 in cash for each share of Reata in a deal it expects to close by the end of this year. Plano, Texas-based Reata focuses…#biogen #reatapharmaceuticals #reata #plano #fda #freidreich #techfidera #tysabri #spinraza #leqembi
Source: Reuters: Health - July 28, 2023 Category: Consumer Health News Source Type: news

Biogen to buy Reata for $6.5 bln to bulk up rare disease portfolio
said it would buy biotech firm Reata Pharmaceuticals (RETA.O) for roughly $6.5 billion to expand its presence in the rare disease drugs market. Biogen will pay $172.50 per share in cash, which represents a 58.9% premium to Reata's last closing price. It expects to finance the acquisition with cash…#biogen #reatapharmaceuticals #reata #bhanvisatija #bengaluru
Source: Reuters: Health - July 28, 2023 Category: Consumer Health News Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20